Torrent Pharmaceuticals’ arm gets warning letter from USFDA for manufacturing violations

25 Nov 2019 Evaluate

Torrent Pharmaceuticals’ US-based subsidiary -- Torrent Pharma Inc's has received warning letter from the US Food and Drug Administration (USFDA) for violations of good manufacturing practices, including lack of properly designed equipment and packing material. The plant's water system was not adequately designed, controlled, maintained, and monitored to ensure it consistently produced water that met specifications and appropriate microbial limits.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3926.95 -97.05 (-2.41%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×